PUBLIC COMPANY
save$BSXBOSTON SCIENTIFIC CORP
$BSX49.37-5.08%Marlborough, MA, USupdated 5h ago
Boston Scientific Corporation (BSC) is an American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
community read0 votes
🐶 often sniffed alongside
top 8- tagAdCom185 co-mentions · 185 sources
- tagPMA Approval156 co-mentions · 156 sources
- tagRecall86 co-mentions · 66 sources
- tag510(k) Clearance29 co-mentions · 29 sources
- company$SLFPFSTANDARD LIFE PLC27 co-mentions · 27 sources
- company$SLFPYSTANDARD LIFE PLC27 co-mentions · 27 sources
- tagCardiology15 co-mentions · 13 sources
- tagUrology12 co-mentions · 10 sources
pipeline
0
marketed
0
phase 3
0
catalysts ytd
104
approvals ytd
0
recalls ytd
1
Pipeline(0)
no pipeline products on record
Upcoming
Recent(90d)
earnings (2)
Active trials
- N/ACHAMPION-AF Clinical Trial
- —IT Matters: The Erectile Restoration Registry
- N/AManaging Pain Using Optimized Sequences by Adjusting Parameters With Independent Current Control
- —Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
- N/AAXIOS™ Gastroenterostomy for Gastric Outlet Obstruction IDE
- —Vercise™ DBS Dystonia Prospective Study
- N/AOPTION-EMEA Clinical Trial
- N/ASafety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
Insider activity
source: SEC Form 4routine RSU / option mechanics (6)
- Mar 2, 26grantPegus Cheryl · director24 sh
- Mar 2, 26grantMorano Susan E · director24 sh
- Mar 2, 26grantWeber Christophe Pierre · director556 sh
- Mar 2, 26grantWeber Christophe Pierre · director323 sh
- Mar 2, 26grantSmith Cathy R · director556 sh
- Mar 2, 26grantSmith Cathy R · director323 sh
🐶 Hiring Signal
next earnings Oct 21, 2026
News
- Boston Scientific cuts guidance again after unveiling restructuring planBoston Scientific is cutting its financial guidance for the second quarter in a row as it gears up for a tough six months ahead.fiercebiotech · 21d ago
- Boston Scientific unveils major restructuring, plots job cuts amid savings driveMedical device maker Boston Scientific has been a prolific dealmaker this year but is now taking a step back as it looks to make changes internally.fiercebiotech · 24d ago
- Early Alert: Percutaneous Catheter Issue from Boston ScientificENROUTE Transcarotid Neuroprotection Systems may have arterial sheath tip separation or partial tip separation during usefda_medwatch · 27d ago
- Biotronik Neuro snaps up spinal cord stimulation portfolio from Soin Neuroscience for next-gen pain projectBiotronik Neuro has acquired a portfolio of spinal cord stimulation patents from the Ohio-based medical device company Soin Neuroscience as the pair look to create “a next-generation spinal cord st…fiercebiotech · 1mo ago
Data sources
last refreshed 16m ago
Found something off?
comments(0)
5-min edit window · permanent after that